BCAB vs ESS · $5.9M cap vs P/E 31, rev $1.89B
Bioatla Inc (BCAB) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
BCAB currently screens at market cap $5.9M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the BCAB and ESS stock pages for the full models.
Not investment advice.